Clinical Trials Logo

Post-Stroke Elbow Spasticity clinical trials

View clinical trials related to Post-Stroke Elbow Spasticity.

Filter by:
  • None
  • Page 1

NCT ID: NCT03563209 Completed - Clinical trials for Post-stroke Elbow Spasticity

Assesment of Post-stroke Elbow Flexor Spasticity in Different Forearm Positions

Start date: March 15, 2018
Study type: Observational

Determination of which muscle is more spastic before injection of the botulinum toxin, and the application of the targeted treatment to that muscle results in more improvement in spasticity. It is known that the muscles that flex elbow in healthy individuals change according to forearm position. While the biceps brachii flexes the forearm in supination, the brachioradialis flexes the forearm in the neutral position. The brachialis muscle acts as a primary flexor muscle when the forearm is in pronation. In this study, hypothesis is that the severity of spasticity differs depending on the forearm position.

NCT ID: NCT02358005 Not yet recruiting - Clinical trials for Post-Stroke Elbow Spasticity

Optimal Dose of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity

Start date: February 2015
Phase: Phase 4
Study type: Interventional

Recently, It is known that the efficacy of botulinum toxin type A (BTX-A) with extracorporeal shock wave therapy (ESWT) is greater than that of BTX-A with electrical stimulation in the management of post-stroke spasticity of the upper limb. However, it was not determined which dose of ESWT is optimal as a adjuvant therapy after BTX-A injection on the upper limb in patients with stroke. Therefore, the aim of this study is to evaluate the optimal dose of ESWT after botulinum toxin type A injection for post-stroke spasticity